Urine tumour DNA to replace surveillance cystoscopy in NMIBC
Bladder cancer sheds DNA straight into urine. A urine test every few months could replace many of the camera examinations patients endure for years.
Urine tumour DNA assays (UroAmp, Bladder EpiCheck, Cxbladder, methylation panels) detect recurrence with sensitivity approaching cystoscopy and can anticipate it by months. Prospective trials of biomarker-guided surveillance intervals are under way.
Pages like this
not linked directly; found by shared links- TermNon-muscle-invasive vs muscle-invasive bladder cancer (NMIBC / MIBC)
Shares Cystoscopy, blue-light imaging & TURBT, Bladder & urothelial cancer.
- PersonSarah-Jane Dawson
Shares MRD / molecular residual disease testing, Liquid biopsy (ctDNA).
- PersonMaximilian Diehn
Shares MRD / molecular residual disease testing, Liquid biopsy (ctDNA).
- IdeaA urine DNA test to decide who with blood in the urine needs a camera test
- PersonAsh A. Alizadeh
Shares MRD / molecular residual disease testing, Liquid biopsy (ctDNA).
- CompanyPersonalis (Tempus)
Shares MRD / molecular residual disease testing, Liquid biopsy (ctDNA).
- IdeaHPV circulating tumour DNA to guide cervical cancer therapy
Shares MRD / molecular residual disease testing, Liquid biopsy (ctDNA).
- IdeaA national residual-disease weather service: serial blood tests for every curatively treated patient, pooled
Shares MRD / molecular residual disease testing, Bladder & urothelial cancer, Liquid biopsy (ctDNA).